Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - disulfiram, quantity: 200 mg - tablet, effervescent - excipient ingredients: tartaric acid; magnesium stearate; povidone; maize starch; microcrystalline cellulose; sodium bicarbonate; colloidal anhydrous silica; purified talc; polysorbate 20 - antabuse tablets are indicated as a deterrent to alcohol comsumption and as an aid in the overall management of selected chronic alcoholic patients involved in an integrated program of counselling and psychiatry. only alcoholic patients who are motivated to abstain from drinking and who are undergoing supportive psychotherapeutic treatment, ancillary to a total program of rehabilitation, should be selected for antabuse administration.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - moxonidine, quantity: 200 microgram - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; crospovidone; povidone; titanium dioxide; hypromellose; iron oxide yellow; macrogol 6000; iron oxide red; macrogol 400 - apo-moxonidine (moxonidine tablets) is indicated for the treatment of hypertension.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - moxonidine, quantity: 400 microgram - tablet, film coated - excipient ingredients: lactose monohydrate; povidone; magnesium stearate; crospovidone; titanium dioxide; hypromellose; iron oxide yellow; macrogol 6000; iron oxide red; macrogol 400 - apo-moxonidine (moxonidine tablets) is indicated for the treatment of hypertension.

Ireland - English - HPRA (Health Products Regulatory Authority)

roche products ltd - diazepam - tablets - 2 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

roche products ltd - diazepam - tablets - 5 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

roche products limited - diazepam - tablets - 5 milligram

Canada - English - Health Canada

searchlight pharma inc - diazepam - tablet - 5mg - diazepam 5mg - benzodiazepines

Canada - English - Health Canada

hoffmann-la roche limited - diazepam - tablet - 10mg - diazepam 10mg - benzodiazepines

Bangladesh - English - DGDA (Directorate General of Drug Administration)

desh pharmaceuticals ltd. - flupenthixol + melitracen - tablet - 500 mcg + 10 mg

United States - English - NLM (National Library of Medicine)

mckesson rxpak inc - diazepam (unii: q3jtx2q7tu) (diazepam - unii:q3jtx2q7tu) - diazepam 10 mg - valium is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. in acute alcohol withdrawal, valium may be useful in the symptomatic relief of acute agitation, tremor, impending or acute delirium tremens and hallucinosis. valium is a useful adjunct for the relief of skeletal muscle spasm due to reflex spasm to local pathology (such as inflammation of the muscles or joints, or secondary to trauma), spasticity caused by upper motor neuron disorders (such as cerebral palsy and paraplegia), athetosis, and stiff-man syndrome. oral valium may be used adjunctively in convulsive disorders, although it has not proved useful as the sole therapy. the effectiveness of valium in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. the physician should periodically reassess the usefulness of the drug for the in